CK2-targeting Synthetic Peptide CIGB-300

A synthetic peptide targeting the substrates of casein kinase 2 (CK2), with potential antineoplastic activity. Upon administration and nucleolar localization, CK2-targeting synthetic peptide CIGB-300 binds to phosphoacceptor sites on the CK2 substrates, in particular the oncoprotein nucleophosmin (B23 or NPM1). This blocks the activation of B23 and induces apoptosis, thereby inhibiting tumor cell growth in susceptible tumor cells. CK2, a protein kinase often overexpressed in a variety of cancer cell types, appears to be correlated with malignant transformation, tumor growth and survival. Overexpression of B23 has been correlated with increased cellular growth and proliferation as well as inhibition of differentiation and apoptosis. (NCI Thesaurus)

YOU MAY ALSO LIKE

CK1/CDK5 Regulation Pathway

Cdk5 is a cyclin dependent protein kinase involved in dopaminergic signaling in the neostriatal region of the brain. The role of…

CIZ1 wt Allele

Human CIZ1 wild-type allele is located in the vicinity of 9q34.1 and is approximately 38 kb in length. This allele, which encodes…

CIZ1 Gene

This gene plays a role in the regulation of DNA replication.

Cixutumumab

A substance being studied in the treatment of some types of cancer. It is a monoclonal antibody that is made in the…

City of Hope Mayday Pain Resource Center Patient Pain Questionnaire

A 16 item ordinal scale that measures a patient's knowledge and experience in managing chronic cancer pain. There is also a Family…

City of Hope Comprehensive Cancer Center

The City of Hope Comprehensive Cancer Center is an independent medical and research institution dedicated to developing innovative, disease-fighting strategies in the…